Digital Biomarkers of Mobility in Parkinson's Disease During Daily Living

Identifying digital biomarkers of mobility is important for clinical trials in Parkinson's disease (PD). To determine which digital outcome measures of mobility discriminate mobility in people with PD from healthy control (HC) subjects over a week of continuous monitoring. We recruited 29 peopl...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Parkinson's disease Vol. 10; no. 3; p. 1099
Main Authors: Shah, Vrutangkumar V, McNames, James, Mancini, Martina, Carlson-Kuhta, Patricia, Nutt, John G, El-Gohary, Mahmoud, Lapidus, Jodi A, Horak, Fay B, Curtze, Carolin
Format: Journal Article
Language:English
Published: Netherlands 01.01.2020
Subjects:
digital outcome measures of mobility
inertial sensors
continuous monitoring
biomarkers
Parkinson’s disease
ISSN:1877-718X, 1877-718X
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Identifying digital biomarkers of mobility is important for clinical trials in Parkinson's disease (PD). To determine which digital outcome measures of mobility discriminate mobility in people with PD from healthy control (HC) subjects over a week of continuous monitoring. We recruited 29 people with PD, and 27 age-matched HC subjects. Subjects were asked to wear three inertial sensors (Opal by APDM) attached to both feet and to the lumbar region, and a subset of subjects also wore two wrist sensors, for a week of continuous monitoring. We derived 43 digital outcome measures of mobility grouped into five domains. An Area Under Curve (AUC) was calculated for each digital outcome measures of mobility, and logistic regression employing a 'best subsets selection strategy' was used to find combinations of measures that discriminated mobility in PD from HC. Duration of recordings was 66±14 hours in the PD and 59±16 hours in the HC. Out of a total of 43 digital outcome measures of mobility, we found six digital outcome measures of mobility with AUC > 0.80. Turn angle (AUC = 0.89, 95% CI: 0.79-0.97) and swing time variability (AUC = 0.87, 95% CI: 0.75-0.96) were the most discriminative individual measures. Turning measures were most consistently selected via the best subsets strategy to discriminate people with PD from HC, followed by gait variability measures. Clinical studies and clinical practice with digital biomarkers of daily life mobility in PD should include turning and variability measures.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1877-718X
1877-718X
DOI:10.3233/JPD-201914